当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 现金流量表

东北制药

(000597)

  

流通市值:65.67亿  总市值:66.50亿
流通股本:14.09亿   总股本:14.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,270,748,871.686,913,916,435.175,261,722,047.383,606,849,971.62
  收到的税费返还6,617,431.3611,357,802.869,727,598.097,043,642.15
  收到其他与经营活动有关的现金91,729,708.51425,414,903.79173,056,766.13119,775,485.09
  经营活动现金流入小计1,369,096,011.557,350,689,141.825,444,506,411.63,733,669,098.86
  购买商品、接受劳务支付的现金781,073,794.243,540,793,039.932,969,341,549.872,143,306,384.51
  支付给职工以及为职工支付的现金244,953,803.81,005,729,405.15775,199,096.99570,123,111.4
  支付的各项税费90,983,114.63412,938,190.33318,031,496.56225,562,573.46
  支付其他与经营活动有关的现金235,196,440.751,284,846,025.141,002,731,544.23689,562,361.37
  经营活动现金流出小计1,352,207,153.426,244,306,660.555,065,303,687.653,628,554,430.74
  经营活动产生的现金流量净额16,888,858.131,106,382,481.27379,202,723.95105,114,668.12
二、投资活动产生的现金流量:
  收回投资收到的现金7,000,00053,156,000.17--
  取得投资收益收到的现金435,972.22---
  处置固定资产、无形资产和其他长期资产收回的现金净额1,504,4005,555,604.81,170,604.834,604.8
  投资活动现金流入小计8,940,372.2258,711,604.971,170,604.834,604.8
  购建固定资产、无形资产和其他长期资产支付的现金18,076,797.4997,784,716.4861,590,908.3450,108,364.6
  投资支付的现金237,000,00050,293,508.78--
  支付其他与投资活动有关的现金--14,000,000-
  投资活动现金流出小计255,076,797.49148,078,225.2675,590,908.3450,108,364.6
  投资活动产生的现金流量净额-246,136,425.27-89,366,620.29-74,420,303.54-50,073,759.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金-7,000--
  其中:子公司吸收少数股东投资收到的现金-7,000--
  取得借款收到的现金430,000,0002,847,800,0002,028,800,0001,818,800,000
  收到其他与筹资活动有关的现金727,850,0003,665,920,0007,322,677,799.164,912,421,414.5
  筹资活动现金流入小计1,157,850,0006,513,727,0009,351,477,799.166,731,221,414.5
  偿还债务支付的现金650,800,0002,334,000,0001,777,250,0001,571,450,000
  分配股利、利润或偿付利息支付的现金11,239,235.73196,902,896.73206,153,565.68191,008,884.81
  支付其他与筹资活动有关的现金253,950,397.594,221,774,037.377,300,720,815.84,951,877,230.66
  筹资活动现金流出小计915,989,633.326,752,676,934.19,284,124,381.486,714,336,115.47
  筹资活动产生的现金流量净额241,860,366.68-238,949,934.167,353,417.6816,885,299.03
四、汇率变动对现金及现金等价物的影响-21,314,318.66-23,810,422.88-8,550,203.22-4,941,908.96
五、现金及现金等价物净增加额-8,701,519.12754,255,504363,585,634.8766,984,298.39
  加:期初现金及现金等价物余额2,852,247,107.942,097,991,603.942,097,991,603.942,097,991,603.94
  期末现金及现金等价物余额2,843,545,588.822,852,247,107.942,461,577,238.812,164,975,902.33
补充资料:
  净利润-217,828,151.01-124,262,718.49
  资产减值准备-175,397,280.07-43,517,471.18
  固定资产和投资性房地产折旧-467,425,909.79-247,650,398.12
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-467,425,909.79-247,650,398.12
  无形资产摊销-49,657,027.75-26,937,331.52
  长期待摊费用摊销-7,766,864.55-3,930,384.7
  处置固定资产、无形资产和其他长期资产的损失--255,861.15--181,512.23
  固定资产报废损失--797,887.48--
  公允价值变动损失--350,622.31--
  财务费用-92,435,882.47-29,254,824.43
  投资损失--7,809,974.98--2,871,681.33
  递延所得税--8,273,369.98--3,952,205.1
  其中:递延所得税资产减少--6,264,453.48--3,314,225.17
    递延所得税负债增加--2,008,916.5--637,979.93
  存货的减少-99,692,436.47-10,293,862.77
  经营性应收项目的减少-101,579,510.12--214,656,097.26
  经营性应付项目的增加--112,792,033.12--172,746,692.92
  其他--115,356.38--143,293.9
  不涉及现金收支的投资和筹资活动金额其他项目---6,740,766.46
  现金的期末余额-2,852,247,107.94-2,164,975,902.33
  减:现金的期初余额-2,097,991,603.94-2,097,991,603.94
  现金及现金等价物的净增加额-754,255,504-66,984,298.39
公告日期2026-04-282026-04-032025-10-282025-08-27
审计意见(境内)标准无保留意见
TOP↑